Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Isis Pharmaceuticals Inc

+ Add to Watchlist

ISIS:US

71.7600 USD 1.6000 2.28%

As of 20:10:00 ET on 03/05/2015.

Snapshot for Isis Pharmaceuticals Inc (ISIS)

Open: 70.4400 Day's Range: 70.2500 - 72.9900 Volume: 3,758,783
Previous Close: 70.1600 52wk Range: 22.2500 - 75.2400 1-Yr Rtn: +37.31%

Stock Chart for ISIS

No chart data available.
  • ISIS:US 71.8100
  • 1D
  • 1M
  • 1Y
70.1600
Interactive ISIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ISIS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3185
Est. EPS (USD) (12/2015) -0.8270
Est. PEG Ratio -
Market Cap (M USD) 8,540.76
Shares Outstanding (M) 119.02
30 Day Average Volume 3,008,000
Price/Book (mrq) 32.9717
Price/Sale (ttm) 39.4798
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ISIS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ISIS

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

Stanley T Crooke "Stan"Chairman/President/CEO/FounderB Lynne ParshallCOO/Secretary
Sarah BoyceChief Business OfficerElizabeth L HougenSenior VP:Finance/CFO
More Company Profile & Key Executives for ISIS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil